(2019-09-04) SHENB'Onix' acquires European certification CE... Delivering a new technology for ‘Liquor odor treatment’
SHENB'Onix' acquires European certification CE... Delivering a new technology for ‘Liquor odor treatment’
“Onix,” a liquid odor treatment device manufactured by SHENB Co., Ltd., acquired the European medical device certification CE. The company said that Onyx was the first in the world to have both hyperhidrosis and liquid odor licensed as high-frequency microneedle equipment.
The CE certification is a certification mark of the European Union integrated standard that satisfies all the requirements of the European Union (EU) Council Directive, and is a certification that domestic manufacturers must acquire in order to enter the European market. It is a demanding certification that must be approved when it meets world-class conditions in terms of overall quality such as efficacy, effectiveness, durability, and safety.
'Onix', which SHENB obtained CE certification, is a device that treats liquid odor and hyperhidrosis by transmitting high frequency through a microneedle. Unlike conventional methods through drugs or incisional surgery, a radical treatment is possible, unlike methods that dramatically reduce side effects and pain and temporarily relieve symptoms such as deodorant and botox. In addition, it helps improve the double chin and skin elasticity.
Onix is a principle that directly irradiates and destroys the apocrine gland in the apocrine gland inside the armpit through a more powerful high-frequency energy implementation and 36 insulated needles, and a cooling device to protect the skin is attached to allow the treatment without damaging the skin. Do. Microneedles are also specially coated, minimizing concerns about skin damage.
Through this, the demand is increasing as it is known as a convenient treatment method that does not interfere with daily life and is effective to patients who have avoided treatment for fear of the existing surgery method that has severe pain and fear of scarring.
Onix is introduced in Korea and Japan as an innovative method to treat odor and hyperhidrosis, and through continuous clinical research, it published an SCI-level paper on the treatment of odor. Through this, I received interest from overseas medical staff early. This CE certification is expected to generate high overseas export revenue by responding to the interest of such foreign medical staff.
Seon-young Kang, CEO of S&B said, “In celebration of the 20th anniversary of its founding, SHENB will further accelerate the development of the global market based on technological innovation and safety.” I am happy to show it off.”
SHENB, which is developing medical devices for skin beauty such as Pladuo, Onix, Vivace, Shemax, Nemesis, etc., and launching Selkit, invigorating the home care beauty device market, is coming September 19, Nonhyeon-dong, Seoul. The 20th anniversary event is scheduled at the Patio Nine Grand Ballroom.